|
시장보고서
상품코드
2051378
당뇨병 앱 시장 : 제품 유형별, OS별, 최종사용자별, 지역별Diabetes Apps Market, By Product Type, By Operating System, By End User, By Geography |
||||||
당뇨병 앱 시장은 2026년에 133억 달러로 추정되고, 2033년까지 370억 3,000만 달러에 이를 전망입니다. 또한 2026-2033년 CAGR 15.7%를 기록할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 133억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 15.70% | 2033년 시장 규모 예측 : | 3,730억 달러 |
세계 당뇨병 앱 시장은 전 세계 당뇨병 유병률 증가를 배경으로 괄목할 만한 성장세를 보이고 있습니다. 당뇨병 앱 은 당뇨병 환자가 혈당, 복약 스케줄, 탄수화물 섭취량, 체중 및 활동 패턴을 효과적으로 관리할 수 있도록 도와줍니다. 이러한 앱은 건강 지표를 추적하고 간병인 및 의료진과 데이터를 쉽게 공유할 수 있는 수단을 제공하여 더 나은 질병 관리를 돕습니다. 커넥티드 헬스 기술의 발전으로 이러한 앱을 통해 보다 진보된 자가 관리 및 원격 모니터링 도구를 개발할 수 있게 되었습니다. 사용 편의성과 환자와 의료진 간의 소통을 강화할 수 있다는 점이 도입에 힘을 실어주고 있습니다.
시장 역학:
세계 당뇨병 앱 시장은 당뇨병에 취약한 고령 인구 증가, 당뇨병 자가 관리에 대한 인식 증가, 모바일 헬스 기술의 발전, 비용 효율적인 관리 솔루션에 대한 니즈 등의 요인에 힘입어 강력한 성장세를 보이고 있습니다. 그러나 민감한 건강정보에 대한 데이터 프라이버시 및 보안에 대한 우려, 그리고 보험 환급 정책의 부재는 시장 확대를 둔화시키는 요인으로 작용하고 있습니다. 디지털 치료제의 부상과 예측 분석을 통합한 AI 기반 앱의 등장은 이 시장의 기업들에게 유망한 기회를 제공합니다.
본 조사의 주요 특징:
세계의 당뇨병 앱 시장에 대해 조사 분석했으며, 2025년을 기준 연도로 하여 예측 기간(2026-2033년) 시장 규모(10억 달러)와 CAGR(연평균 성장률)을 예측한 보고서입니다.
이 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
이 보고서는 다음과 같은 매개 변수를 기반으로 세계 당뇨병 앱 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
이 조사에 포함된 주요 기업으로는 Medtronic, Abbott Laboratories, Dexcom, F. Hoffman-La Roche, Insret Corporation, Tandem Diabetes Care, Gluco, Dario Health Corporation, One Drop, LifeScan, Ascensia Diabetes Care Holdings AG, Health2Sync, Agamatrix, Ipsomed Holding AG, Bioscans, Inc. 아센시아 다이아베티스 케어 홀딩스 AG, 헬스투싱크, 아가매트릭스, 입소메드 홀딩스 AG, 비트오가 포함됩니다.
이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
이 세계 당뇨병 앱 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계 당뇨병 앱 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 당뇨병 앱 시장 : 제품 유형별, 2021년-2033년
제5장 세계의 당뇨병 앱 시장 : 운영체제별, 2021년-2033년
제6장 세계의 당뇨병 앱 시장 : 최종사용자별, 2021년-2033년
제7장 세계의 당뇨병 앱 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
LSH 26.06.18Diabetes Apps Market is estimated to be valued at USD 13.30 Bn in 2026 and is expected to reach USD 37.03 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 13.30 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 15.70% | 2033 Value Projection: | USD 37.03 Bn |
The global diabetes apps market is witnessing substantial growth driven by the rising prevalence of diabetes worldwide. Diabetes management apps help individuals with diabetes effectively monitor blood glucose levels, medication schedules, carbohydrate intake, and weight/activity patterns. They provide an easily accessible way to track health metrics and share data with caregivers which can help manage the condition better. Advancements in connected health technologies are enabling the development of more sophisticated self-care and remote monitoring tools through such apps. Their ease of use and potential to enhance communication between patients and healthcare providers is boosting adoption.
Market Dynamics:
The global diabetes apps market is experiencing strong growth driven by factors such as the growing elderly population base prone to diabetes, increasing awareness about diabetes self-care, advancements in mobile health technologies, and need for cost-effective management solutions. However, data privacy and security concerns regarding sensitive health information and lack of reimbursement policies are some factors slowing market expansion. The rising trend of digital therapeutics and advent of AI-powered apps integrating predictive analysis offer lucrative opportunities for players in this market.
Key Features of the Study:
This report provides in-depth analysis of the global diabetes apps market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diabetes apps market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic, Abbott Laboratories, Dexcom, F. Hoffmann-La Roche, Insulet Corporation, Tandem Diabetes Care, Glooko, Inc., DarioHealth Corporation, One Drop, LifeScan, Inc., Ascensia Diabetes Care Holdings AG, Health2Sync, AgaMatrix, Ypsomed Holding AG, and BeatO
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global diabetes apps market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetes apps market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Blood Glucose Tracking Apps
- Comprehensive Diabetes Management Platforms
- Insulin Dose Calculators
- Diet & Nutrition Management Apps
- Exercise & Fitness Apps
- Operating System Insights (Revenue, USD Bn, 2021 - 2033)
- Android
- iOS
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Self/Home Healthcare
- Hospitals & Clinics
- Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic
- Abbott Laboratories
- Dexcom
- F.Hoffmann-La Roche
- Insulet Corporation
- Tandem Diabetes Care
- Glooko, Inc.
- DarioHealth Corporation
- One Drop
- LifeScan, Inc.
- Ascensia Diabetes Care Holdings AG
- Health2Sync
- AgaMatrix
- Ypsomed Holding AG
- BeatO
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Diabetes Apps Market, By Product Type
- Global Diabetes Apps Market, By Operating System
- Global Diabetes Apps Market, By End User
- Global Diabetes Apps Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Diabetes Apps Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Blood Glucose Tracking Apps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Comprehensive Diabetes Management Platforms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Insulin Dose Calculators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diet & Nutrition Management Apps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Exercise & Fitness Apps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Diabetes Apps Market, By Operating System, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Android
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- iOS
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Diabetes Apps Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Self/Home Healthcare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Diabetes Apps Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Operating System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Operating System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Operating System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Operating System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Operating System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Operating System, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dexcom
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F.Hoffmann-La Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Insulet Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tandem Diabetes Care
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Glooko, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- DarioHealth Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- One Drop
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LifeScan, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ascensia Diabetes Care Holdings AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Health2Sync
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AgaMatrix
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ypsomed Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BeatO
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
